Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A potential survival benefit in coronary artery bypass grafting with micro-axial temporary pump recovery in patients with reduced left ventricular ejection fraction.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2026
Same author

Strain echocardiography for assessment of cardiac graft function following donation after circulatory death heart transplantation.

JHLT open·2026
Same author

Clinical course and outcomes of antibody-mediated rejection after heart transplant in the contemporary era.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.

JAMA cardiology·2026
Same author

Ex vivo heart perfusion induces time dependent inflammatory activation in human donor hearts.

NPJ cardiovascular health·2026
Same author

Outcomes following coronary artery bypass grafting with temporary left ventricular assist device support.

Frontiers in cardiovascular medicine·2026

Related Experiment Video

Updated: May 7, 2026

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
12:24

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

9.6K

Progress Toward Cardiac Xenotransplantation.

Richard N Pierson1,2, Jay A Fishman2, Gregory D Lewis3

  • 1Division of Cardiac Surgery, Department of Surgery (R.N.P., D.A.D., M.R.C., L.B., J.C.M., A.M.A.), Massachusetts General Hospital and Harvard University, Boston.

Circulation
|October 5, 2020
PubMed
Summary
This summary is machine-generated.

Pig heart xenografts in genetically modified pigs survived over 90 days with a clinical drug regimen. This breakthrough in cardiac xenotransplantation suggests clinical translation is achievable soon.

Keywords:
cardiomyopathiesgenetic engineeringheart failureheart transplantationheterograftsmyocardial ischemiatransplantation, heterologous

More Related Videos

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
09:12

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation

Published on: April 27, 2019

9.9K
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

3.0K

Related Experiment Videos

Last Updated: May 7, 2026

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
12:24

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

9.6K
A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
09:12

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation

Published on: April 27, 2019

9.9K
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

3.0K

Area of Science:

  • Transplantation immunology
  • Xenotransplantation research
  • Genetically modified organisms

Background:

  • Cardiac xenotransplantation offers a potential solution to donor heart shortages.
  • Previous xenotransplantation studies faced challenges with hyperacute and chronic rejection.
  • Advances in genetic modification and immunosuppression are crucial for success.

Purpose of the Study:

  • To summarize key mechanistic insights driving recent progress in pig heart xenotransplantation.
  • To highlight the role of genetic modifications in pig design for xenotransplantation.
  • To discuss therapeutic strategies enabling long-term survival of cardiac xenografts.

Main Methods:

  • Utilized genetically modified pigs to minimize immune rejection.
  • Employed a clinically applicable drug treatment regimen for immunosuppression.
  • Focused on understanding and overcoming immunological barriers in xenotransplantation.

Main Results:

  • Achieved consistent survival of life-supporting pig heart xenograft recipients beyond 90 days.
  • Demonstrated the efficacy of combined genetic modification and therapeutic strategies.
  • Established a new benchmark for long-term cardiac xenograft survival.

Conclusions:

  • Recent advancements suggest pig heart xenografts are nearing clinical applicability.
  • Reproducibility of these findings is key to establishing clinical translation benchmarks.
  • Mechanistic insights into pig design and therapy are critical for early clinical translation.